Drug for kidney injury after cardiac surgery does not reduce need for dialysis

(The JAMA Network Journals) Among patients with acute kidney injury after cardiac surgery, infusion with the antihypertensive agent fenoldopam, compared with placebo, did not reduce the need for renal replacement therapy -- dialysis -- or risk of death at 30 days, but was associated with an increased rate of abnormally low blood pressure, according to a study published in JAMA.